SCHEMBL14973189

SCHEMBL14973189

CN(N)C(=O)c1cnn(C)c1COc1ccc(C(F)(F)F)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.42
ALDH1A1 P00352 1/20 0.41
GRM4 Q14833 1/20 0.39
PPARD Q03181 2/20 0.38
PPARA Q07869 1/20 0.38
FLT3 P36888 1/20 0.38
DHODH Q02127 1/20 0.38
SLC6A5 Q9Y345 3/20 0.38
PPARG P37231 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38
HTR2B P41595 1/20 0.38
MCHR1 Q99705 1/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.37
NPC1 O15118 1/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14973243 0.88 BCHE (0.41) MAOBALDH1A1GRM4PPARDPPARA
SCHEMBL14972954 0.85 KDM4C (0.47) MAOBALDH1A1GRM4PPARDPPARA
SCHEMBL14972951 0.85 MAOB (0.52) MAOBALDH1A1GRM4PPARDPPARA
SCHEMBL14972953 0.84 ALDH1A1 (0.52) MAOBALDH1A1GRM4PPARDPPARA
SCHEMBL14973018 0.83 MAOB (0.44) MAOBALDH1A1GRM4PPARDPPARA
SCHEMBL14973308 0.82 PDE2A (0.38) MAPT
SCHEMBL14972952 0.81 MAPT (0.52) MAOBALDH1A1PPARDPPARGNPC1
SCHEMBL14973190 0.81 SLC6A5 (0.43) MAOBALDH1A1GRM4PPARDPPARA
Hydrochloric Acid SCHEMBL14973129 0.80 SLC6A5 (0.42) MAOBALDH1A1GRM4PPARDPPARA
SCHEMBL14973102 0.80 HMOX1 (0.38) MAOBALDH1A1GRM4FLT3SLC6A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE GRIN2C, GRIN2B, GRIN3A MAOB 1115/4885ALDH1A1 2263/4885GRM4 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.